系统性高血压对没有视网膜病变的患者视网膜层的影响
Gayathri Jagadesh1, Rajalakshmi A R, Swathi Nagarajan
1Department of Ophthalmology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed To Be University), Puducherry, India.
Journal of hypertension
|June 11, 2025
概括
系统性高血压 (HTN) 导致视网膜内层显著变薄,包括周和黄斑视网膜神经纤维层 (pRNFL和mRNFL) 和黄斑结节细胞内状层 (mGC-IPL),即使没有视网膜病变. 较长的HTN持续时间与较大的视网膜稀疏相关.
科学领域:
- 眼科医生 眼科 眼科
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 视网膜神经元损伤,通过光学连贯断层扫描 (OCT) 检测到视网膜内部层的稀薄,可以是系统性疾病的指标.
- 系统性高血压 (HTN) 是心血管和脑血管疾病的主要危险因素,可能会影响眼部结构.
研究的目的:
- 研究系统性高血压对没有临床明显高血压视网膜病变的患者视网膜内层的亚临床影响.
- 在高血压患者中,量化周状视网膜神经纤维层 (pRNFL),黄斑视网膜神经纤维层 (mRNFL) 和黄斑结节细胞内状层 (mGC-IPL) 的厚度.
主要方法:
- 一项横截面的观察性研究,涉及50名没有视网膜病变的高血压患者和50名年龄和性别匹配的对照.
- 用光谱域光连贯性断层扫描 (OCT) 来测量pRNFL,mRNFL和mGC-IPL厚度.
- 对高血压组和对照组的测量结果进行了比较.
主要成果:
- 与对照组相比,高血压患者的pRNFL,mRNFL和mGC-IPL厚度显著降低 (所有患者的p <0.05).
- 在高血压持续时间较长和prnfl和mgc-ipl的较大稀释之间发现了显著的关联 (p <0.01).
- 诸如性别,HTN家族史和抗高血压药物的类型等因素并没有显著影响内视网膜厚度.
结论:
- 系统性高血压导致视网膜内层显著变薄,即使没有视网膜病变,OCT也可以检测到.
- 高血压的持续时间是与视网膜神经退行症进展相关的关键因素.
关键词:
这就是为什么B.P.B.B.B.在CMT上使用CMT.这是一个HMOD.在HTN中,HTN是HTN.这是一个HTNRHTNR.在IHEC中,它是最重要的.IOPOP IOPOP IOPOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP机构人类伦理委员会其他国家和地区.血压 血压 血压 血压中部黄斑厚度 黄斑厚度持续时间 持续时间结节细胞内部的形层是形层.这种高血压,高血压.通过高血压介导的器官损伤.高血压视网膜病变 这是一种高血压视网膜病变.眼内压力 眼内压力mGC-IPL 公司在 mRNFL 中.马库拉 (Macula macula) 是一个很大的动物.黄斑结节细胞内状层内状层斑点和视网膜神经纤维层是一种神经纤维层.神经退行症的神经退行症光学连贯性断层扫描技术在pRNFL中,周周状的视网膜神经纤维层.视网膜神经纤维层是一种神经纤维层视网膜稀释 视网膜稀释相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
3
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
3
Hypertension II: Pathophysiology
2
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
2
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Hypertension I: Introduction
2
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
2
Glaucoma: Overview
527
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
527
Antihypertensive Drugs: Direct Renin Inhibitors
506
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
506


